Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking — Stella

Recruiting

Back to Keratoconus, Unstable trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Pacific Clear Vision Institute, Eugene, Oregon

Key details

Phase

Early testing

Sponsor

Pacific Clear Vision Institute

Enrollment target

~300 participants

Started

September 2019

Primary completion

December 2029

Age range

12 Years – 45 Years

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov